BiotechTube
Indigo BioAutomation

Indigo BioAutomation

Indianapolis, United States· Est.
indigobio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

Indigo BioAutomation is a private, revenue-generating software company founded in 2000 that specializes in AI-driven laboratory automation and data analytics. Its core products, ASCENT and ARQ, are cloud-based SaaS platforms designed to streamline complex data analysis for LC/GC-MS/MS and PCR workflows, targeting moderate- to high-complexity laboratory-developed tests (LDTs). The company serves leading laboratories and test manufacturers, focusing on improving operational tempo, data integrity, and regulatory alignment through intelligent software that reduces manual review and provides actionable insights.

AI / Machine LearningDigital HealthDrug Delivery

Technology Platform

Cloud-based SaaS platforms (ASCENT for LC/GC-MS/MS, ARQ for PCR) that use AI, machine learning, and high-performance computing to automate complex laboratory data analysis, enforce quality rules based on lab SOPs, and provide collaborative review tools.

Funding History

2
Total raised:$15M
Series A$12M
Seed$3M

Opportunities

The growing demand for laboratory-developed tests (LDTs) and complex molecular diagnostics creates a need for flexible, compliant data analysis software.
The digital transformation of labs and shift to cloud-based SaaS solutions presents a major opportunity for scalable, remote-access platforms like Indigo's.
Increasing laboratory pressure to improve throughput, reduce errors, and manage costs with limited personnel drives adoption of intelligent automation.

Risk Factors

Faces intense competition from large, established laboratory informatics vendors and agile startups.
Regulatory risk is significant as software must comply with evolving standards for data integrity in clinical environments (e.g., CLIA, FDA).
Laboratory inertia and long sales cycles for replacing legacy systems can hinder market penetration and growth.

Competitive Landscape

Competes in the laboratory informatics and data analysis software market against major instrument vendors (e.g., Thermo Fisher, Agilent, Waters) who offer their own proprietary software suites, as well as independent software providers. Differentiation is based on unified multi-instrument workflows, embedded AI/ML insights, a focus on complex LDTs, and a cloud-native SaaS delivery model.

More companies in Digital Health & Biotech SaaS →More companies in United States →